Multifunctional neuroprotective-neurorescue drugs for Parkinson's disease

被引:3
|
作者
Van der Schyf, Cornelis J. [1 ]
Geldenhuys, Werner J. [1 ]
Youdim, Moussa B. H. [1 ]
机构
[1] Eve Topf & Natl Parkinson Fdn US, Fac Med, Ctr Excellence Neurodegenerat Dis, Efron St,POB 9697, IL-31096 Haifa, Israel
关键词
adenosine; dual mechanism; iron chelation; rasagiline;
D O I
10.2217/14796708.2.4.411
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Parkinson's disease (PD) is a severe neurodegenerative disorder, with no drugs currently approved to prevent the neuronal cell loss characteristic of brains of patients suffering from PD. Owing to the complex etiology of PD, an innovative approach towards neuroprotection or neurorescue may be the use of multifunctional pharmaceuticals that target an array of pathological pathways, each of which is believed to contribute to the cascade that ultimately leads to neuronal cell death. In this review, we discuss examples of novel multifunctional ligands that may have potential as neuroprotective-neurorescue therapeutics in PD. The compounds discussed originate from synthetic chemistry as well as from natural sources.
引用
收藏
页码:411 / 423
页数:13
相关论文
共 50 条
  • [41] Neurotoxicological and neuroprotective elements in Parkinson's disease
    Kostrzewa, Richard M.
    Segura-Aguilar, Juan
    NEUROTOXICITY RESEARCH, 2002, 4 (02) : 83 - 86
  • [42] The study of neuroprotective drugs in the striatal and the MFB 6-hydroxydopamine rat model for Parkinson's disease
    Mertens, B.
    Massie, A.
    Michotte, Y.
    Sarre, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 73 - 73
  • [43] Neurorescue-neurorestoration of dopaminergic neurons by rasagiline and its propargyl moiety in Parkinson's disease
    Weinreb, Orly
    Bar-Am, Orit
    Amit, Tamar
    Youdim, Moussa B. H.
    JOURNAL OF NEURAL TRANSMISSION, 2008, 115 (10) : 1477 - 1477
  • [44] Neuroprotective strategies in Parkinson's disease -: An update on progress
    Mandel, S
    Grünblatt, E
    Riederer, P
    Gerlach, M
    Levites, Y
    Youdim, MBH
    CNS DRUGS, 2003, 17 (10) : 729 - 762
  • [45] Obstacles to the Development of a Neuroprotective Therapy for Parkinson's Disease
    Stocchi, Fabrizio
    Olanow, C. Warren
    MOVEMENT DISORDERS, 2013, 28 (01) : 3 - 7
  • [46] THE NEUROPROTECTIVE MECHANISMS OF ACUPUNCTURE TREATMENT IN PARKINSON'S DISEASE
    Park, Hi-Joon
    Kim, Seung-Tae
    Moon, Woongjoon
    Kim, Seung-Nam
    Chae, Younbyoung
    Lee, Hyejung
    JOURNAL OF PHYSIOLOGICAL SCIENCES, 2009, 59 : 51 - 51
  • [47] Neuroprotective actions of sex steroids in Parkinson's disease
    Bourque, Melanie
    Dluzen, Dean E.
    Di Paolo, Therese
    FRONTIERS IN NEUROENDOCRINOLOGY, 2009, 30 (02) : 142 - 157
  • [48] Curcumin: A Potential Neuroprotective Agent in Parkinson's Disease
    Mythri, R. B.
    Bharath, M. M. Srinivas
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (01) : 91 - 99
  • [49] Dietary modifications in Parkinson's disease: A neuroprotective intervention?
    Shah, Shital P.
    Duda, John E.
    MEDICAL HYPOTHESES, 2015, 85 (06) : 1002 - 1005
  • [50] In search of the neuroprotective mechanism of thiazolidinediones in Parkinson's disease
    Ridder, Dirk A.
    Schwaninger, Markus
    EXPERIMENTAL NEUROLOGY, 2012, 238 (02) : 133 - 137